 WARREN, N.J., March 09, 2021 GLOBE NEWSWIRE -- Aquestive Therapeutics, Inc. NASDAQ:AQST, a pharmaceutical company focused on developing and commercializing differentiated products that address patients unmet needs and solve therapeutic problems, today reported financial results for the fourth quarter and full year ended December 31, 2020 and provided an update on recent developments in its business. 